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Abstract
Background: Apoptosis is a highly ordered and orchestrated multiphase process controlled by the numerous
cellular and extra-cellular signals, which executes the programmed cell death via release of cytochrome c
alterations in calcium signaling, caspase-dependent limited proteolysis and DNA fragmentation. Besides the general
modifiers of apoptosis, several tissue-specific regulators of this process were identified including HAX1 (HS-1
associated protein X-1) - an anti-apoptotic factor active in myeloid cells. Although HAX1 was the subject of various
experimental studies, the mechanisms of its action and a functional link connected with the regulation of
apoptosis still remains highly speculative.
Findings: Here we provide the data which suggests that HAX1 may act as a regulator or as a sensor of calcium.
On the basis of iterative similarity searches, we identified a set of distant homologs of HAX1 in insects. The applied
fold recognition protocol gives us strong evidence that the distant insects’ homologs of HAX1 are novel
parvalbumin-like calcium binding proteins. Although the whole three EF-hands fold is not preserved in vertebrate
our analysis suggests that there is an existence of a potential single EF-hand calcium binding site in HAX1. The
molecular mechanism of its action remains to be identified, but the risen hypothesis easily translates into
previously reported lines of various data on the HAX1 biology as well as, provides us a direct link to the regulation
of apoptosis. Moreover, we also report that other family of myeloid specific apoptosis regulators - myeloid
leukemia factors (MLF1, MLF2) share the homologous C-terminal domain and taxonomic distribution with HAX1.
Conclusions: Performed structural and active sites analyses gave new insights into mechanisms of HAX1 and MLF
families in apoptosis process and suggested possible role of HAX1 in calcium-binding, still the analyses require
further experimental verification.
Background
Apoptosis - the programmed cell death - is one of the
basic processes in regulation of cell count in ontogen-
esis. Early models defined apoptosis as a relatively sim-
ple a few step process starting from the initiation by
one of pro-apoptotic signals and driving to the final
endonucleolytic cleavage of genomic DNA and mem-
brane blebbing. The identification of novel molecular
mechanisms involved in this process suggests that the
overall picture is far more complex and that the current
cell status is directly related to the balance between pro-
and anti-apoptotic factors. The induction of apoptosis
may be caused by a number of events including disrup-
tion of genome, oncogenes’ activation, stimulation of
various receptors, disorders in calcium homeostasis, free
radicals or other damaging factors like radiation [1,2].
Finally, the limited number of apoptosis execution
mechanisms is modulated by a wide range of signals [1].
The cell survival depends on homeostasis of signals
involved in induction and inhibition of both prolifera-
tion and apoptosis. Within a set of regulators of apopto-
sis, several key proteins were already identified (i.e. Bcl-
2, IAP, survivin) [3]. Two of the proteins constitute
myeloid regulators of apoptosis: HS-1- associated pro-
tein X-1 (HAX1) and myeloid leukemia factors (MLF1,
MLF2). Although these proteins were the subjects of * Correspondence: lucjan@bioinfo.pl
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ity remain to be only partially discovered.
HS-1 associated protein X-1 (HAX1), is a multifunc-
tional protein first identified in a yeast two hybrid system
as a partner of HS-1 (hematopoietic lineage cell-specific
protein I) [4]. So far, HAX1 has been detected in various
cellular compartments and is known to be involved in a
number of different processes. The high level of its
expression is observed in mitochondrion and nuclear
matrix, although HAX1 was also found in endoplasmic
reticulum, apical membrane of hepatocytes and nuclear
envelope [5]. HAX1 is expressed ubiquitously among var-
ious tissues, mainly in skeletal muscle and heart [6] and
in a number of cancer tissues [7,8]. Although HAX1 is
known as a multifunctional protein, the exact mechanism
of its action remains unexplained [9].
Currently, there are several observations that are link-
ing HAX1 and cell apoptosis together. As reported by
Vafiadaki et al. ap u t a t i v eH A X 1 ’s anti-apoptotic role
m a yr e s u l tf r o ma ni n h i b i t i o no fc a s p a s e9 .H A X 1
repress post-mitochondrial caspase 9 activation, cell
death during hypoxia and following re-oxygenation and
its overexpression protects cardiac myocytes from apop-
tosis [10]. Here, the C-terminal part of HAX1 interacts
with caspase-9 at the region corresponding to residues
175-206 of human ortholog (GenBank identifier - gi|
158562115), even though, both N-terminal and C-term-
inal domains are required for full anti-apoptotic func-
tion [11,12]. Additionally, HAX1 interacts with other
partners from the caspase cascade. Caspase 3 (CASP3)
cleaves HAX1 at residue Asp127, while HAX1 over-
expression inhibits CASP3 catalytic activity and blocks
the initiation of apoptosis [13].
Several previous studies suggested HAX1 involvement
in calcium homeostasis [6,10]. Phospholamban (PLN) -
a transmembrane regulator of the contractility in the
heart and calcium homeostasis - binds to HAX1 within
internal part of protein (residues 203-245 of human
ortholog - gi|158562115, compare Figure 1B). The
HAX1-PLN complex plays an important role in cardiac
cell survival and the presence of PLN enhances the anti-
apoptotic potential of HAX1. PLN regulates activity of
the sarcoplasmic reticulum Ca
2+ - ATP-ase pump (SER-
CA2a) - the regulator of heart calcium homeostasis [6].
Formation of the HAX1-PLN complex is modulated and
interaction with HAX1 is reduced by either phosphory-
lation of PLN or increased concentration of Ca
2+ [6].
Additionally, HAX1 when bound to PLN is redistributed
from mitochondrion to endoplasmatic reticulum (ER)
[6]. ER localization is also crucial for interaction of
HAX1 with polycystic kidney disease 2 (PKD2) apopto-
sis regulating protein involved in Ca
2+ signaling in kid-
ney cells. Here, HAX1 acts as an adaptor between PKD2
and cortactin - a key regulator of PKD2 function [14].
HAX1 was previously described as a hairpin-structure
RNA binding protein [15]. This observation was initially
raised on the basis of interaction with vimentin’s mRNA
3’UTR [15]. Sarnowska et al. suggested also that HAX1
plays a role in destabilization of mRNA through binding
of Polb (polymerase beta) mRNA.
Since multifunctional activity and a number of inter-
actions involved mainly in regulation of apoptosis are
the key processes in cell regulation, this protein plays
important role in several diseases and carcinogenesis.
One of the most important functions of HAX1 is the
regulation of myeloid homeostasis. This protein is cru-
cial for proper inner mitochondrial membrane potential
and for protecting myeloid cells from apoptosis [16,17].
Congenital deficiency of HAX1, leads to the develop-
ment of Kostmann syndrome [17], via mitochondrion-
dependent deregulation of apoptosis, which results in an
infantile genetic agranulocytosis. Notable, in the later
phase Kostmann syndrome can lead to the development
of acute myeloid leukemia [17].
T h ed a t ao nt h ea c t i v i t yo fm yeloid leukemia factor 1
(MLF1) is far more limited. At first, MLF1 was identified
in an oncogenic fusion gene with nucleophosmin (NPM-
MLF1). This fusion gene is generated by t(3;5)(q25.1;
q34) translocation [18-20] and is linked with both acute
myeloid leukemia (AML) and myelodysplastic syndrome
(MDS). MLF1 is expressed in a number of tissues,
including skeletal muscle, heart, brain and hematopoie-
tic stem cells. Despite several reports about MLF family,
mechanisms of its activity have not been reported. The
previous analyses contain quite inconsistent data sug-
gesting variable range of its actions. MLF1 protein pro-
duct is mainly targeted to cytoplasm and is potentially
involved in regulation of mitosis (cell cycle exit) and cell
differentiation processes [19,21]. Several lines of evi-
dence suggest that MLF1 also participates in induction
of apoptosis when fused with NPM [20,22]. MLF1 - as a
component of NPM-MLF1 complex - is known to be
involved in various pathways of carcinogenesis. It nega-
tively regulates the progression of cell cycle inhibiting
cell growth through the accumulation of tumor suppres-
sor protein p53 (TP53) [23]. Additionally, MLF1 in
hemopoetic lineage is able to switch erythroleukemic
cells to the monoblastoid phenotype. It can also deregu-
late pluripotent progenitor cells, participate in ineffective
hematopoiesis and transformation into leukemia [20].
Similarly to MLF1, the chromosomal translocations and
deletions of myeloid leukemia factor 2 (MLF2) locus were
also observed in acute leukemia [24], but no direct studies
were performed to identify the specific mechanism of its
action. Both proteins share 64% of sequence similarity
between human homologs (gi|194328680 and gi|
54695734, MLF1 and MLF2 respectively), but no experi-
mental studies on MLF2 were published recently. The lack
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base - Sanger’s Protein Families (Pfam). Although
sequences of MLF1 (Q2TLE5_MLF1_HUMAN) and
MLF2 (Q15773_MLF2_HUMAN) were deposited under
the PfamA accession PF10248, the title of the entry as well
as the description of the domain, are related to non-homo-
logous protein MLF1-interacting protein (MLF1IP)
(Q71F23|CENPU_HUMAN), what shows a misleading
assignment of the MLF proteins. Comparison of MLF and
MLF1IP proteins shoved only marginal similarity score
(expected value above 2).
Identification of various pro- and anti-apoptotic pathways
is a challenging problem. So far, no significant homology of
the two discussed protein families connected to other
proteins of similar function was reported. Several previous
studies described inconsistent data on the structure of
HAX1. Sharp et al. postulated that there is a presence of a
transmembrane helix in the C-terminal region of open
reading frame (position 261-273) [25], while other research-
ers suggested that, the motif is shorter than an ordinary
transmembrane helix [4]. Suzuki et al. reported that the N-
terminal region of HAX1 shows weak similarity to NIP3
protein which is up-regulated in oxidative stress conditions
in cardiac myocytes. It is also involved in apoptosis which
causes mitochondrial defects [26]. Another two regions
consisting of residues 37- 56 and 74-89 of human HAX1 is
reported to be homologous to anti-apoptotic protein, there-
fore, BCL2 (B-cell lymphoma 2) creating so called
Figure 1 A. The overview of the domain composition of HAX1 and MLF proteins. B. Interaction sites within human HAX1 protein.
C. Mutation sites within HAX1 (X-nonsense mutation, fs - frameshift).
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[11,16,26]. The detailed revision of the presented bioinfor-
matic evidence reported in the above cited articles shows
that original reports contain inappropriate application of
bioinformatic methods and could not be reproduced. To
summarize, as of now, no clear data on homology of either
HAX1 or MLFs has previously been reported.
Previously we were able to successfully apply bioinfor-
matic methods of fold recognition and identification of
distant homology to analyze genes participating in
important biological processes. These include ALK
kinase regulator NIPA [3], family of transcription factors
homologous to TFCP2 regulating transcription of glo-
bins [27] and several other human and viral genes
[28,29]. In this work we present a bioinformatic
approach to elucidate the molecular function of HAX1
and MLF1 homologs.
Methods
Sequences of HAX1 and MLF1 proteins homologs were
collected using PSI-BLAST (default settings) [30] in NR
(non-redundant) database of NCBI (National Center for
Biotechnology Information; http://www.ncbi.nlm.nih.
gov). The sequences of each protein were clustered at
70% of sequence identity with CD-HIT [31] in order to
select representative collection of protein sequences,
with preserved functional motifs. The final protein
sequence collections were aligned with ClustalW [32]
a n dP C M A[ 3 3 ] .B a s e do nt h ea l i g n m e n tc o n s e r v e d
regions were selected. Conserved sequence regions of
both families were subjected to iterative PSI-BLAST
searches at NCBI resources. Sequences from each pro-
tein family were submitted to the Protein Structure Pre-
diction MetaServer (http://bioinfo.pl/meta; [34]) - server
joining a number of secondary structure prediction
(PsiPred [35]), fold recognition (3D-PSSM [36], INUB
[37], SAM_T06 [38]) and homology modeling methods
(FFAS03 [39], MetaBasic [40]). Based on secondary
structure predictions, location of critical residues and
physicochemical properties of amino acids multiple
sequence alignment of HAX1 and MLF protein families
was manually corrected. Protein homology models of
HAX1 parvalbumin-like domain were calculated with
Modeler v. 9 based on 1RJP PDB structure [41] and
implemented in Discovery Studio 2.1 (Accelerys Inc.).
Visualizations of the obtained structures were performed
with PyMol http://pymol.sourceforge.net/.
Results and discussion
Identification of protein domains
Based on sequence searches for the whole length of
HAX1 and MLFs no significant similarity in NR data-
base (NCBI) was detected. Similar searches applied only
with the most conserved C-terminal part of HAX1 as a
query, revealed a significant match to C-terminal
domain of Myeloid Leukemia Factor family (Figure 1A).
The comparison of similar regions of both protein
families, together with the results of secondary structure
prediction, confirmed the initial homology searches. The
secondary structure prediction analysis performed for
both protein families revealed a common pattern of sec-
ondary structure elements (three beta strands and an
alpha helix at the carboxyl terminus of the proteins; Fig-
ure 2). The conserved domain is localized at positions
209-287, 149-234, 115-200 of human HAX1 (gi|
158562115), MLF1 (gi|194328680) and MLF2 (gi|
54695734) respectively. The most conserved region used
as an initial query, spanned the potential b-sheet. The
last common a-helix is preceded by an additional strand
and marginal prediction of a-helix in MLF family. The
final multiple sequence alignment of C-terminal parts of
HAX1 and MLF protein families shown in Figure 2 was
created by manual correction of the obtained multiple
sequence alignment (ClustalW, PCMA).
The high conservation of C-terminal domain of these
proteins suggest its importance in protein’sf u n c t i o no f
apoptosis regulation. Within C-terminal regions of the
two protein families, several similarities can be observed.
As shown in Figure 2, common distribution of the sec-
ondary structure elements, a high conservation of sev-
eral key residues and properties of corresponding amino
acids supports their homology and suggest a common
fold for these two protein families. Preserved distribu-
tion of charged and hydrophobic amino acids, presence
of characteristic glycine residues between b-sheets of
both protein families point to similarity of the predicted
domain structure. Detailed analyses revealed no assign-
ments to any known records in protein families data-
bases (Pfam, SMART).
Although a number of protein structure prediction
methods were applied via the Protein Structure Predic-
tion MetaServer, no significant similarity to known pro-
tein structures was detected, indicating the probable
new fold type. Since no proteins of homologous experi-
mentally determined structure were found, fold recogni-
tion for HAX1 and MLFs C-terminal domain could not
be performed.
The analysis of taxonomic distribution of homologous
sequences of both families revealed additional similari-
ties of these two protein families - both HAX1 and
MLFs families are well conserved through Vertebrata,
but surprisingly additional homologues of both families
were found in genomes of insects.
Fold recognition of the N-terminal calcium binding
domain
Notably, HAX1 homologs in insects are less divergent of
remaining sequences of the whole protein family (whole
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form similar function). The application of several
threading and profile-profile methods via Protein Struc-
ture Prediction MetaServer for fragments of insects
HAX1 sequences showed marginal similarity scores to
parvalbumin’s EF-hand calcium binding motifs in the
N-terminal region of HAX1 (gi|122937737:57-171 - sup-
ported by Meta Basic, INUB and 3D-PSSM; 3D-Jury
score: 60.20).
Parvalbumin belongs to the superfamily of calcium
binding proteins [42]. The overall function of this family
is related to transport and storage of calcium ions. Pre-
sent mainly in muscle and neurons; it is responsible for
muscle relaxation and calcium transport from myofibrils
to the sarcoplasmic reticulum. It may also affect some
cellular properties such as: extension of the G1 cell
cycle phase, increase of cell motility and extension of
mitotic rate in ovarian carcinoma calls [42]. From the
structural point of view, parvalbumin is composed of six
a-helices forming three helix-loop-helix motifs known
as EF-hand motifs. Hydrophobic surfaces of the helices
form a core part of this fold. These motifs between two
adjacent amphipathic helices contain a loop of different
length coordinating calcium ions mainly by carboxylate
groups of aspartic and glutamic acid side chains. The six
helices form three pairs - the acidic residues (Asp, Glu)
at loops between the second and the third pair of helices
are involved in binding of ions. The loop between first
helix pair, because of the absence of critical amino acids
is unable to bind calcium ions [43,44].
The manual adjustment of multiple sequence align-
ment of Insecta HAX1 with parvalbumin sequences
confirms the overall similarity of these two protein
families. The final alignment of HAX1 sequences of
insects with imposition of EF-hand motif is shown in
Figure 3. The prediction of secondary structure of
HAX1 was highly consistent with observed six helices
of parvalbumin (three consecutive EF-hand motifs).
The analysis of biochemical properties of aligned resi-
dues pointed to the conserved pattern of hydrophobic
surfaces of helices building the fold. Surprisingly, the
presence of acidic residues that are critical for calcium
ions binding within HAX1 sequences suggested that
the first and second EF-hand motifs are involved in
forming of calcium binding sites, while in parvalbumin,
such motifs are located within second and third motif
[43,44]. The acidic residues within the third motif,
located between fifth and sixth helix, are in the fact
not preserved in instects’ HAX1. Visualization of
HAX1 models revealed that only within the second
Figure 2 Multiple sequence alignment of HAX1 and MLF C-terminal domains. The corresponding sequences were defined with GenBank
entries (coded with GenBank identifier - gi) and origin organism. Numbers in brackets refer to the positions of presented sequence fragments,
numbers in square brackets indicate the number of residues removed for clarity of alignment. Predicted secondary structure elements (Psipred)
are coded with letters (H - a-helix, E - extended).
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acids involved in formation of binding site can analo-
gously to typical EF-hand motif (typically for parvalbu-
min) bind calcium ions. The role of potential site
within first EF-hand motif remains highly speculative
(Additional file 1).
The fold recognition for insects’ HAX1 gives a strong
suggestion that this protein initially evolved as a regu-
lator of calcium homeostasis. When compared to
insect HAX1 proteins only a single EF-hand motif con-
sisting of two alpha-helices is preserved in vertebrate
HAX1 proteins. The detailed alignment of the HAX1
proteins of vertebrates with recognized calcium bind-
ing motif of insects’ suggested the presence of a single
active calcium binding site (Figure 3). This motif was
preserved throughout the whole clade (Insecta)a n dt h e
presence of hydrophobic residues within helices along
with pattern of acidic binding site within loops. How-
ever, the active site in vertebrates HAX1 proteins
diverged from typical EF-hand motif with additional
20-28 amino acids within the calcium binding loop
region (Figure 4). Furthermore, the precise confirma-
tion of the motif’s functionality requires detailed ana-
lyses. The sequence conservation and secondary
structure predictions failed to identify any known
potential functional motif. Previous studies suggested
that EF-hand remains functional only in multimeric
composition [45]. Although within vertebrates’ HAX1,
we identified only a single motif corresponding to the
classic three EF-hand domain our prediction can still
be correct since calcium ion binding can occur by
forming a dual EF-hand domain composition during
formation of HAX1 dimers [46]. Summarizing, in the
current state of data, the presence of active EF-hand
motif in vertebrates’ HAX1 is still speculative and
detailed experimental studies are needed to confirm
this hypothesis.
Location of HAX1 interaction sites
According to the current state of the knowledge, specific
function of HAX1 is a final result of its various interac-
tions. At first HAX1 was identified as a binding partner
of HS1 (hematopoietic lineage cell-specific protein I), a
substrate of Src family tyrosine kinase. HS1 protein is
expressed specifically in hematopoietic cells and impli-
cated in signal transduction in B cells. The complex for-
mation proceeds between N-terminal part of HS1
(residues 27-66) and C-terminal part of HAX1. This
probably results in altered signal transduction from the
Ag receptor (B lymphocyte antigen receptor) to intracel-
lular organelles. When associated with HAX1, HS1 is
accumulated in mitochondrial membrane [26]. Beside
this, a number of other interactions with cellular and
viral proteins has been described [25,47-51]. Such a
broad spectrum of interacting proteins of unrelated
structures suggests that HAX1 is a protein involved in
intracellular signaling and is harboring various intracel-
lular molecules (hub protein). Most of the known inter-
action sites within HAX1 are located among two
regions defined previously as putative functional
domains (all the known interaction sites are shown on
Figure 1B). This further supports the hypothesis of two
functional domains of HAX1 spaced by additional
unstructured protein-binding region.
Apoptosis regulation
Several studies indicated that HAX1 is involved in apop-
tosis regulation [10,13]. Previous analyses linked apopto-
sis event with interactions of HAX1 with proteins of
caspase cascade (caspase 3 and 9). Both N-terminal and
C-terminal domains are required for full anti-apoptotic
function [11,12]. Caspase 3 interacts with a region
within predicted calcium binding site (cleaves HAX1 at
residue Asp127). HAX1 when over-expressed, inhibits
CASP3 catalytic activity and blocks the initiation of
Figure 3 Multiple sequence alignment of insects HAX1 and Parvalbumin (PVALB) calcium binding domains. The corresponding
sequences were defined with GenBank entries (coded with GenBank identifier - gi) and origin organism. Numbers in brackets refer to the
positions of presented sequence fragments. The observed (Protein Data Bank entry 1RTP_1, 1RJV_A) and predicted (Psipred) secondary structure
elements are coded with letters (H - a-helix,E - b-strands). Calcium binding sites within parvalbumin proteins are marked with x, putative calcium
binding residues of HAX1 are marked with asterisks (*).
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caspase-9 at the region corresponding to residues 175-
206 of human ortholog (gi|158562115). HAX1 repress
post-mitochondrial caspase 9 activation and cell death
during hypoxia-reoxygenation and HAX1 overexpression
protects cardiac myocytes from apoptosis [10]. Location
of HAX1 interaction sites with both caspases within
functional regions described in this report partially sup-
ports the involvement of both of these regions in apop-
tosis and proper function of HAX1.
Additionally, several points and frame shift mutations
within HAX1 were previously described. This genetic
alterations associated with neutrophil depletion [52] in
fact affect mainly functional regions described here
(compare Figure 1C).
RNA binding properties of HAX1
The previous data reports that mRNA binding occurred
within C-terminal part of the protein only in a diametric
form of HAX1. The overall picture of mechanism of
HAX1 binding to RNA is still not clear. According to
the results of assays performed with HAX1 deletion
mutants, a potential nucleic acid binding region is
located within carboxyl terminus of HAX1.
According to predictions of secondary structure - the
C-terminal region contains three conserved fragments
which seem to be in extended conformation, likely to
form a beta-sheet. This local conformation is conserved
also in MLFs. Although some RNA-binding folds consist
mainly of beta-sheet, our analyzes did not allow to map
a distant similarity of HAX1 or MLFs to any known
RNA-binding proteins. There are two major explana-
tions for this situation: either HAX1 forms a novel
RNA-binding protein, or this C-terminal fragment forms
rather a platform closing together other protein agents,
where some possess RNA binding activity [9].
Conclusions
Although the mechanisms of HAX1 and MLF1 activity
are not well described, the applied state-of-the-art of
protein structural bioinformatics revealed several com-
mon traces of their biology. In the history of the mole-
cular evolution of HAX1-MLF1 families we can indicate
three distinct points.
The C-terminal domain of HAX1-MLF1 families
revealed a sequence homology which can suggest the
existence of novel protein structural domain potentially
involved in RNA (or other protein) binding.
Similar taxonomic distribution of homologous
sequences and conservation of C-terminal domain of
both families emphasize its importance in proteins com-
mon function of apoptosis regulation. It is worth to
note that we made an interesting observation that
HAX1 and MLFs are present only in co-existence in a
number of genomes. This might suggest that there is
either physical interaction between their protein pro-
ducts or that there is a novel negative feed-back
mechanism in regulation of related biological processes.
Additionally, N-terminald o m a i no fH A X 1f a m i l yw a s
described. HAX1 homologues in insects showed
Figure 4 Multiple sequence alignment of insects and vertebrates HAX1 proteins putative calcium binding motifs. The corresponding
sequences were defined with GenBank entries (coded with GenBank identifier - gi) and origin organism. Numbers in brackets refer to the
positions of presented sequence fragments. Predicted secondary structure elements (Psipred) are coded with letters (H - a-helix,E - b-strands).
Putative calcium binding residues of vertebrates HAX1 are marked with x.
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binding motifs with the second EF-hand motif pointed
as a calcium binding site. In vertebrates’ HAX1 - only a
single EF-hand motif consisting of two a-helices with
additional 20-28 amino acids within the calcium binding
loop region is preserved. Performed structural and active
sites analyses gave new insights into mechanisms of
HAX1 and MLF families in apoptosis process and sug-
gested possible role of HAX1 in calcium-binding, still
the analyses require further experimental verification.
In the presented report we describe the application of
several methods of homology search and protein struc-
ture prediction in drafting of hypotheses on function of
HAX1. In the light of this new data, additional experi-
mental work is needed to confirm and summarize a pic-
ture of HAX1 and MLFs biology.
Additional material
Additional file 1: Model of Aedes aegypti HAX1 parvalbumin-like
domain. Putative two EF-hand calcium binding site of Aedes aegypti
HAX1 parvalbumin-like domain modeled on the template of parvalbumin
(PDB: 1RJP). A. N-terminal EF-hand motif - critical residues marked in
blue; B. C-terminal EF-hand motif - critical residues likely to be involved
in formation of calcium binding module were shown in red.
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